These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17968744)

  • 1. Mechanism-based inactivation of human cytochrome P450 enzymes: strategies for diagnosis and drug-drug interaction risk assessment.
    Venkatakrishnan K; Obach RS; Rostami-Hodjegan A
    Xenobiotica; 2007; 37(10-11):1225-56. PubMed ID: 17968744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism-based inactivation of human cytochrome p450 enzymes and the prediction of drug-drug interactions.
    Obach RS; Walsky RL; Venkatakrishnan K
    Drug Metab Dispos; 2007 Feb; 35(2):246-55. PubMed ID: 17093004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism-based inactivation of human cytochromes p450s: experimental characterization, reactive intermediates, and clinical implications.
    Hollenberg PF; Kent UM; Bumpus NN
    Chem Res Toxicol; 2008 Jan; 21(1):189-205. PubMed ID: 18052110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions.
    Obach RS; Walsky RL; Venkatakrishnan K; Gaman EA; Houston JB; Tremaine LM
    J Pharmacol Exp Ther; 2006 Jan; 316(1):336-48. PubMed ID: 16192315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicological significance of mechanism-based inactivation of cytochrome p450 enzymes by drugs.
    Masubuchi Y; Horie T
    Crit Rev Toxicol; 2007 Jun; 37(5):389-412. PubMed ID: 17612953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro-in vivo extrapolation of CYP2D6 inactivation by paroxetine: prediction of nonstationary pharmacokinetics and drug interaction magnitude.
    Venkatakrishnan K; Obach RS
    Drug Metab Dispos; 2005 Jun; 33(6):845-52. PubMed ID: 15788540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism-based inhibition of cytochrome P450 enzymes: an evaluation of early decision making in vitro approaches and drug-drug interaction prediction methods.
    Grime KH; Bird J; Ferguson D; Riley RJ
    Eur J Pharm Sci; 2009 Feb; 36(2-3):175-91. PubMed ID: 19013237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition and induction of human cytochrome P450 enzymes: current status.
    Pelkonen O; Turpeinen M; Hakkola J; Honkakoski P; Hukkanen J; Raunio H
    Arch Toxicol; 2008 Oct; 82(10):667-715. PubMed ID: 18618097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of different approaches to predict metabolic drug-drug interactions.
    Einolf HJ
    Xenobiotica; 2007; 37(10-11):1257-94. PubMed ID: 17968745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting in vivo drug interactions from in vitro drug discovery data.
    Wienkers LC; Heath TG
    Nat Rev Drug Discov; 2005 Oct; 4(10):825-33. PubMed ID: 16224454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug interactions.
    Boobis A; Watelet JB; Whomsley R; Benedetti MS; Demoly P; Tipton K
    Drug Metab Rev; 2009; 41(3):486-527. PubMed ID: 19601724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-drug interactions via mechanism-based cytochrome P450 inactivation: points to consider for risk assessment from in vitro data and clinical pharmacologic evaluation.
    Venkatakrishnan K; Obach RS
    Curr Drug Metab; 2007 Jun; 8(5):449-62. PubMed ID: 17584016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug interactions of H2-receptor antagonists involving cytochrome P450 (CYPs) enzymes: from the laboratory to the clinic.
    Rendić S
    Croat Med J; 1999 Sep; 40(3):357-67. PubMed ID: 10411963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel model for the prediction of drug-drug interactions in humans based on in vitro cytochrome p450 phenotypic data.
    Lu C; Miwa GT; Prakash SR; Gan LS; Balani SK
    Drug Metab Dispos; 2007 Jan; 35(1):79-85. PubMed ID: 17020957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of CYP-mediated drug interactions in vivo using in vitro data.
    Foti RS; Wahlstrom JL
    IDrugs; 2008 Dec; 11(12):900-5. PubMed ID: 19051152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generalized proteochemometric model of multiple cytochrome p450 enzymes and their inhibitors.
    Kontijevskis A; Komorowski J; Wikberg JE
    J Chem Inf Model; 2008 Sep; 48(9):1840-50. PubMed ID: 18693719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of drug metabolism and interactions on the basis of in vitro investigations.
    Pelkonen O; Turpeinen M; Uusitalo J; Rautio A; Raunio H
    Basic Clin Pharmacol Toxicol; 2005 Mar; 96(3):167-75. PubMed ID: 15733211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The conduct of in vitro and in vivo drug-drug interaction studies: a PhRMA perspective.
    Bjornsson TD; Callaghan JT; Einolf HJ; Fischer V; Gan L; Grimm S; Kao J; King SP; Miwa G; Ni L; Kumar G; McLeod J; Obach SR; Roberts S; Roe A; Shah A; Snikeris F; Sullivan JT; Tweedie D; Vega JM; Walsh J; Wrighton SA;
    J Clin Pharmacol; 2003 May; 43(5):443-69. PubMed ID: 12751267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting drug-drug interactions from in vitro drug metabolism data: challenges and recent advances.
    Obach RS
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):81-9. PubMed ID: 19152216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approach to the prediction of the contribution of major cytochrome P450 enzymes to drug metabolism in the early drug-discovery stage.
    Emoto C; Murase S; Iwasaki K
    Xenobiotica; 2006 Aug; 36(8):671-83. PubMed ID: 16891248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.